Adenosine, the heart, and coronary circulation
- PMID: 1937658
- DOI: 10.1161/01.hyp.18.5.565
Adenosine, the heart, and coronary circulation
Abstract
Adenosine is known to regulate myocardial and coronary circulatory functions. Adenosine not only dilates coronary vessels, but attenuates beta-adrenergic receptor-mediated increases in myocardial contractility and depresses both sinoatrial and atrioventricular node activities. The effects of adenosine are mediated by two distinct receptors (i.e., A1 and A2 receptors). A1 adenosine receptors, located in atrial and ventricular myocardium and sinoatrial/atrioventricular nodes, are responsible for inhibition of adenylyl cyclase activity. A2 adenosine receptors, located in coronary endothelial and smooth muscle cells, are responsible for stimulation of this enzyme activity. During increased myocardial oxygen demand due to rapid pacing and exercise, although both coronary blood flow and adenosine concentrations in the myocardium and coronary efflux increased, there is no clear consensus explaining its cause and effect relation at present. However, ischemia/reperfusion-induced coronary hyperemia is believed to be mostly attributed to released adenosine, and it has been proven that adenosine attenuates the severity of ischemia due to its coronary vasodilatory action. The beneficial effects of adenosine during ischemia/reperfusion processes do not seem simple. This is because myocardial ischemia and reperfusion injury is caused by 1) activated leukocytes and platelets, 2) ATP depletion and calcium overload of myocardium, and 3) catecholamine release from the presynaptic nerves as well as 4) the impaired coronary circulation. Intriguingly adenosine attenuates all of these deleterious actions and thereby attenuates ischemia/reperfusion injury. Indeed, adenosine attenuates the severity of contractile dysfunction (myocardial stunning) and limits the infarct size. Thus, administration of adenosine or potentiators of adenosine production in the ischemic myocardium may be beneficial for the attenuation of ischemic and reperfusion injuries, although further clinical investigations are necessary.
Similar articles
-
Protective effects of adenosine in myocardial ischemia.Circulation. 1992 Mar;85(3):893-904. doi: 10.1161/01.cir.85.3.893. Circulation. 1992. PMID: 1537125 Review.
-
[Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].Z Kardiol. 1992 Nov;81(11):596-609. Z Kardiol. 1992. PMID: 1471397 Review. German.
-
Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.Circulation. 1993 Jul;88(1):235-44. doi: 10.1161/01.cir.88.1.235. Circulation. 1993. PMID: 8319338
-
Effect of transient coronary occlusion on coronary blood flow autoregulation, vasodilator reserve and response to adenosine in the dog.J Am Coll Cardiol. 1991 Sep;18(3):858-67. doi: 10.1016/0735-1097(91)90813-o. J Am Coll Cardiol. 1991. PMID: 1869750
-
Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit.Circulation. 1993 Aug;88(2):709-19. doi: 10.1161/01.cir.88.2.709. Circulation. 1993. PMID: 8339431
Cited by
-
Non-ischemic myocardial preconditioning.Mol Cell Biochem. 1998 Sep;186(1-2):201-3. Mol Cell Biochem. 1998. PMID: 9774202 Review.
-
Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?Cells. 2025 Aug 7;14(15):1219. doi: 10.3390/cells14151219. Cells. 2025. PMID: 40801651 Free PMC article. Review.
-
Preconditioning in cardiac anesthesia…… where are we?Ann Card Anaesth. 2019 Oct-Dec;22(4):412-421. doi: 10.4103/aca.ACA_116_18. Ann Card Anaesth. 2019. PMID: 31621678 Free PMC article. Review.
-
Endothelial dysfunction, subangiographic atheroma, and unstable symptoms in patients with chest pain and normal coronary arteriograms.Clin Cardiol. 2000 Sep;23(9):645-52. doi: 10.1002/clc.4960230904. Clin Cardiol. 2000. PMID: 11016013 Free PMC article.
-
Stress and Rest Pulmonary Transit Times Assessed by Cardiovascular Magnetic Resonance.Cardiol Rev. 2024 May-Jun 01;32(3):243-247. doi: 10.1097/CRD.0000000000000495. Epub 2022 Dec 29. Cardiol Rev. 2024. PMID: 36728820 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources